Vimarsana
Biggest News Aggregation in the World

Page 35 - Work Productivity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Work Productivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Work Productivity Today - Breaking & Trending Today

Narayana Murthy Suggests 70-Hour Work Week To Youngsters, Sparks Debate - Vimarsana News

Narayana Murthy Suggests 70-Hour Work Week To Youngsters, Sparks Debate

Narayana Murthy presented some historical examples - of Germany and Japan after the Second World War - to underline the critical role of discipline and enhanced productivity.

Source: ndtv.com
Narayana Murthy's '70-hour work week' advice for youngsters divides internet | Bengaluru - Vimarsana News

Narayana Murthy's '70-hour work week' advice for youngsters divides internet | Bengaluru

Murthy made the remarks while appearing on the first episode of 3one4 Capital's podcast ‘The Record’. | Bengaluru News

Tildrakizumab Significantly Improves Work Productivity in Moderate to Severe Plaque Psoriasis - Vimarsana News

Tildrakizumab Significantly Improves Work Productivity in Moderate to Severe Plaque Psoriasis

Tildrakizumab significantly improved work productivity and reduced work activity impairment in patients with moderate to severe plaque psoriasis, highlighting this treatment's quality of life benefits.

Is Sleep Restriction Therapy a Cost-Effective Treatment for Insomnia? - Vimarsana News

Is Sleep Restriction Therapy a Cost-Effective Treatment for Insomnia?

Nurse-delivered sleep restriction therapy in primary care reduces insomnia symptoms and may be used as a treatment for insomnia disorder.

Abrocitinib Improves Itch, Sleep, Work Productivity in Patients With Atopic Dermatitis - Vimarsana News

Abrocitinib Improves Itch, Sleep, Work Productivity in Patients With Atopic Dermatitis

Patients with atopic dermatitis saw improvements in itch severity, sleep, and work productivity when treated with abrocitinib.